Formulation and Evaluation of Aripiprazole Oral Disintegrating Tablets

نویسندگان

چکیده

Aim: This work aims to develop oral disintegrating tablets from solid dispersion of aripiprazole that are capable enhancing solubility.
 Methodology: Aripiprazole an antipsychotic is a BCS class IV drug with Oral bioavailability 87%. To enhance the solubility this dispersions were prepared by using combination ?-Cyclodextrin and PVP K30 in 1:1, 1:2 physical mixture solvent evaporation method. The analyzed for all parameters excipient interactions. was optimized preparation direct compression technique different concentrations various natural super disintegrants namely Tapioca starch, Amorphophallus campanulactus, synthetic Sodium starch glycolate, crospovidone.
 Results: FTIR showed excipients compatible each other. Among formulations SCD6 (Drug: ?-cyclodextrin) shows high percentage release i.e., 98.58±0.28% 45 min, found be 0.954±0.32mg/ml. Percentage practical yield 98.36±0.14% content 97.31±0.04%. formulation tablets. post-compression within limits. all, F3 containing tapioca 7.5% possess better disintegration time (28±1.52sec) in-vitro dissolution (98.64±0.29% 45min).
 Conclusion: It can concluded incorporated very useful approach efficient manner.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Formulation & Evaluation of Oral Disintegrating Tablets of Lamotrigine Solid Dispersions

Lamotrigine is used in the treatment of CNS disorders, particularly epilepsy; pain; oedema; multiple sclerosis and psychiatric indications including bipolar disorder. Lamotrigine belongs to biopharmaceutical classification systems, BCS class II (Low solubility & High permeability). In addition, it requires immediate therapeutic action hence the main objective of this study is to improve the sol...

متن کامل

Formulation of Desloratadine Oral Disintegrating Tablets

Article history: Received on: 13/08/2014 Revised on: 09/09/2014 Accepted on: 15/10/2014 Available online: 27/11/2014 Desloratadine (DS) is a tricyclic antihistaminic, characterized by bitter taste and slight water solubility. The aim of this study is to prepare DS as orally disintegrating tablets (ODT) to mask the bitter taste and improve compliance. Twelve different placebo ODT (F1-F12) were p...

متن کامل

formulation & evaluation of oral disintegrating tablets of lamotrigine solid dispersions

lamotrigine is used in the treatment of cns disorders, particularly epilepsy; pain; oedema; multiple sclerosis and psychiatric indications including bipolar disorder. lamotrigine belongs to biopharmaceutical classification systems, bcs class ii (low solubility & high permeability). in addition, it requires immediate therapeutic action hence the main objective of this study is to improve the sol...

متن کامل

Formulation and Evaluation of Orally Disintegrating Tablets of Rosuvastatin

Rosuvastatin is a Dyslipidaemic Agents, which acts by inhibition of HMG-CoA reductase enzyme. Used in the treatment of hyperlipidemia. Therefore the present investigation was to design a formulation of orally disintegrating tablets of Rosuvastatin. Orally disintegrating tablets of Rosuvastatin were formulated by Superdisintegrant addition method by direct compression technique. All the fourteen...

متن کامل

Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets

The present investigation deals with development of mouth disintegrating tablets of rizatriptan benzoate to produce the intended benefits. Mouth disintegrating tablets of rizatriptan benzoate were prepared using superdisintegrants crospovidone, carboxymethylcellulose calcium, Indion 414 and Indion 234 using the direct compression method. The tablets prepared were evaluated for thickness, unifor...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of pharmaceutical research international

سال: 2022

ISSN: ['2456-9119']

DOI: https://doi.org/10.9734/jpri/2022/v34i49b36429